Effects of furosemide on the racing times of horses with exercise-induced pulmonary hemorrhage.

The research explores the impact of furosemide medication on the racing performance of horses suffering from exercise-induced pulmonary hemorrhage (EIPH). No significant change in race times was observed after the treatment.

Objective of the Study

• The study aimed to investigate the impact of furosemide, a diuretic medication, on the racing performance of horses suffering from EIPH, a common medical condition in racehorses characterized by bleeding from the lung area during exercise. The researchers compared race times and finishing positions of horses before and after the administration of the medication.

Study Design and Sample

• The study involved three groups of horses diagnosed with EIPH through varying diagnostic methods: observational hemorrhage at nostrils post-workout or race (group 1), endoscopic examination revelation of hemorrhage (group 2), and nostril hemorrhage during or directly after a race (group 3).
• A fourth group of horses, who were not given furosemide, were also studied during the same period for comparison purposes. These horses were chosen randomly.

Evaluation Methodology

• The researchers used analysis of covariance as the statistical method, having the horses’ time per distance as the dependent variable. They also considered variables such as the horses’ estimated value, race interactions, and other relevant covariates like race distance, track variant, and winning time per distance.
• Findings from each group were compared, specifically races 1 through 5 (before medication) with races 6 through 10 (after medication).

Results of the Study

• The study concluded that the administration of furosemide did not yield any significant improvement to the racing times of the horses, particularly in the case of group 1 horses.